CordovaCann (LVRLF) Return on Sales (2018 - 2019)

CordovaCann (LVRLF) recorded quarterly Return on Sales of 0.83% in Q2 2019, up 149.79% quarter-over-quarter from 1.67% in Q1 2019.

CordovaCann (LVRLF) Return on Sales (2018 - 2019) Analysis & Trends

CordovaCann's Return on Sales history runs 2 years deep, the most recent figure standing at 0.83% for Q2 2019.

In Q2 2019, Return on Sales changed N/A year-over-year to 0.83%; the TTM figure through Jun 2019 stood at 176.18% (changed N/A YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
Return on Sales was 0.83% for Q2 2019 at CordovaCann, up from 1.67% in the prior quarter.
In the past five years, Return on Sales ranged from a high of 0.83% in Q2 2019 to a low of 3.8% in Q1 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROS (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn	0.00%
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn	0.00%
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn	0.00%
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn	0.00%
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn	0.00%
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn	0.00%
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn	-0.02%
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn	0.00%
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn	0.00%
10	CordovaCann	-	-	-	-

Download Data